Prevalence and risk of thrombocytopenia with valproic acid: Experience at a psychiatric teaching hospital

Pharmacotherapy

Volumn 21, Issue 11, 2001, Pages 1325-1330

  Conley, Erin L ^a   Coley, Kim C ^a   Pollock, Bruce G ^a   DaPos, Stacey V ^b   Maxwell, RaeAnn ^a   Branch, Robert A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CARBAMAZEPINE; CLOZAPINE; COTRIMOXAZOLE; DONEPEZIL; HEPARIN; SEROTONIN UPTAKE INHIBITOR; TICLOPIDINE; VALPROIC ACID;

ADULT; AGED; AGING; ARTICLE; DRUG MEGADOSE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; MENTAL HOSPITAL; PREVALENCE; RISK FACTOR; TEACHING HOSPITAL; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTIMANIC AGENTS; CHI-SQUARE DISTRIBUTION; DOSE-RESPONSE RELATIONSHIP, DRUG; HOSPITALS, PSYCHIATRIC; HOSPITALS, TEACHING; HUMANS; MIDDLE AGED; PLATELET COUNT; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOCYTOPENIA; VALPROIC ACID;

EID: 0035169085     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.21.17.1325.34418     Document Type: Article

References (21)

1. Valproate in the treatment of bipolar disorder: Literature review and clinical guidelines
2. Drug treatment of mania: A critical review
3. The efficacy and tolerability of divalproex sodium in elderly demented patients with behavioral disturbances
4. Treatment of dementia with behavioral disturbance using divalproex or a combination of divalproex and a neuroleptic
5. Treatment of resistant schizophrenia with valproate and neuroleptic drugs
6. Augmentation of risperidone with Valproic acid
7. Sodium valproate and thrombocytopenia
8. Haematological disturbances during long-term valproate therapy
9. Sodium valproate and platelet function
10. Dose-related thrombocytopenia and macrocytic anemia associated with valproate use in bipolar disorder
11. Sodium valproate and thrombocytopenia
12. Thrombocytopenia associated with sodium valproate treatment
13. Sodium valproate and platelet count
14. Hematologic manifestations of long-term valproate therapy
15. Safety and efficacy of divalproex sodium monotherapy in partial epilepsy
16. Blood dyscrasias with carbamazepine and valproate: A pharmacoepidemiological study of 2, 228 patients at risk
17. Pharmacokinetics of valproic acid in the elderly
18. The effect of aspirin on valproic acid metabolism
19. Occurrence of thrombocytopenia in psychiatric patients taking valproate
20. Interaction between valproic acid and aspirin in epileptic children: Serum protein binding and metabolic effects